Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03150589
Brief Title: A Study to Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD)

First Submitted : May 10, 2017
First Submitted that Met QC Criteria : May 11, 2017
First Posted : May 12, 2017

Certification/Extension First Submitted : January 28, 2019
Certification/Extension First Submitted that Met QC Criteria : January 28, 2019
Certification/Extension First Posted : January 30, 2019

Last Update Submitted that Met QC Criteria : June 24, 2020
Last Update Posted : June 26, 2020